BioCorRx (BICX) Total Liabilities (2010 - 2026)

BioCorRx has disclosed Total Liabilities across 17 years of filings, most recently posting $13.9 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $13.9 million, down 25.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.9 million (down 25.02% YoY), and the FY2025 annual result was $13.7 million, up 7.32% from the prior year.
• Total Liabilities came in at $13.9 million for Q1 2026 at BioCorRx, up from $13.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $20.3 million in Q3 2025 to a low of $7.9 million in Q1 2022.
• The 5-year median for Total Liabilities is $11.2 million (2024), against an average of $12.2 million.
• Across the five-year window, Total Liabilities jumped 69.4% in 2025 and declined 25.02% in 2026, its largest moves.
• BioCorRx's Total Liabilities stood at $9.0 million in 2022, then climbed by 15.31% to $10.3 million in 2023, then increased by 23.21% to $12.7 million in 2024, then climbed by 7.32% to $13.7 million in 2025, then climbed by 2.0% to $13.9 million in 2026.
• The last three Total Liabilities figures came in at $13.9 million (Q1 2026), $13.7 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.